Literature DB >> 23581403

Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients.

Zijin Chen1, Xiaonong Chen, Jingyuan Xie, Xiaobo Ma, Fang Zhong, Liang Hou, Huawei Ling, Xiao Li, Hong Ren, Nan Chen.   

Abstract

BACKGROUND: Our study aimed to investigate the factors associated with elevated plasma FGF23 (cFGF23) levels in maintenance hemodialysis (MHD) patients and to determine whether plasma FGF23 level is related to aortic artery calcification (AAC).
METHODS: This study included 120 MHD patients and 20 controls. The FGF23 level was measured using a C-terminal assay and AAC was detected by a lateral lumbar X-ray plain.
RESULTS: Plasma FGF23 levels were significantly higher among dialysis patients compared to controls: FGF23 level of 27691.42 ± 55646.41 RU/mL in MHD patients versus 49.89 ± 23.94 RU/mL in health people. Significant correlations were observed between FGF23 levels and vintage, intact parathyroid hormone (iPTH), serum phosphate, total calcium, 25(OH)D, urea nitrogen (BUN), and serum creatinine (SCR). Stepwise multiple regression analysis showed that the independent parameters associated with FGF23 level were serum phosphate, total calcium, parathyroid hormone (PTH), SCR, and prealbumin. There were 73 patients (60.83%) with visible calcification in the abdominal aorta. Bivariate analysis showed that AAC score correlated with FGF23, phosphate, total calcium, vintage, age, and diastolic blood pressure. Forward logistic analysis showed that the independent parameters associated with AAC were age, total protein, and Lg FGF23.
CONCLUSION: Plasma FGF23 level is significant increased in hemodialysis patients and is independently associated with AAC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23581403     DOI: 10.3109/0886022X.2013.781844

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

Review 1.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

2.  Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zhihui Yao; Congxia Wang; Qiaona Zhang; Shan Ma; Baosong Gui; Chaoyang Duan
Journal:  Int Urol Nephrol       Date:  2017-09-21       Impact factor: 2.370

3.  Calcification Biomarkers, Subclinical Vascular Disease, and Mortality Among Multiethnic Dialysis Patients.

Authors:  Jessica Fitzpatrick; Esther D Kim; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Jose M Monroy-Trujillo; Rulan S Parekh
Journal:  Kidney Int Rep       Date:  2020-08-06

Review 4.  Functional diversity of fibroblast growth factors in bone formation.

Authors:  Yuichiro Takei; Tomoko Minamizaki; Yuji Yoshiko
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

5.  Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.

Authors:  Xiao-Nong Chen; Zi-Jin Chen; Xiao-Bo Ma; Bei Ding; Hua-Wei Ling; Zhong-Wei Shi; Nan Chen
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

6.  Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients.

Authors:  Riri Andri Muzasti; Netty Delvrita Lubis
Journal:  Tzu Chi Med J       Date:  2021-03-09

Review 7.  Research Progress on the Relationship between Coronary Artery Calcification and Chronic Renal Failure.

Authors:  Jun Lai; Gael Akindavyi; Qiang Fu; Zhi-Liang Li; Hui-Min Wang; Li-Hua Wen
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

8.  The predictive value of coronary artery calcification score combined with bone mineral density for the 2-year risk of cardiovascular events in maintenance hemodialysis patients.

Authors:  Jingfeng Huang; Lingling Bao; Yuning Pan; Qingqing Lu; Yaqin Huang; Qianjiang Ding; Fangjie Shen; Qiuli Huang; Xinzhong Ruan
Journal:  Int Urol Nephrol       Date:  2021-07-19       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.